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ABSTRACT 
Receptor tyrosine kinases ( RTKs) are a family of cell-surface receptors that have an 
important role in an array of cellular responses including cell migration, proliferation 
and differentiation ( Fanti el ol.. 1993 ). RT Ks and their ligands arc important 
C()!11pPncnts in tl1c (ktcrrnination of cell fate through signalling path\vays that arc 
acti,ated durine both invertebrate and \'Crlcbratc development (Pawson and Bernstein. 
1990) 
The Ror subt:m1ih of Rn:s :ire· thought to be important for the development of the 
1wrnius s, stem as they arc c;;prcsscd highly in the nervous system in the developing 
embryo, but expression is minimal in adulls. Three receptors in this subfamily have been 
idc>ntifiCcL Rorl and Ror2 from humans (lVlasiakowski and Carro IL 1992) and Dror from 
Drosophila t \\ ilson el al., 1993 ). This thesis invc,lwd the isolation and characterisation 
of the fom1h gene in this family /Jror2 from Drosophila melanogasler. 
Degenerate oligonucleotides to conserved regions of the tyrosine kinase domain of 
RTKs were used to PCR amplify a 200 bp fragment from genomic DNA A 1, genomic 
library was screened with the labelled fragment in order to isolate the gene. The 
rc:sulting clone was subcloned and sequenced to obtain the complete: sequence ofDror2. 
The 3' end of the gene was dekrrnined by RT-PCR. The transcriptional start point was 
identified by using 5' RACE and sequencing of the amplification product. Expression of 
Dror2 was examined using Northern Blot hybridisation and in situ hybridisation to 
whole mount embryos. 
The 725 amino acid mature Dror2 protein comprises an extracellular domain containing 
the signal peptide, cysteine-rich region and kringle domain, a hydrophobic 
transmembrane domain and the intracellular domain containing a catalytic kinase 
domain. Three intrans were identified, one in the middle of the cysteine-rich region and 
two flanking the kringle domain. 
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1. INTRODUCTION 
1.1 RECEPTOR TYROSINE KINASES (RTKS) 
Receptor tyrosine kinases (RTKs) are a family of cell-surface receptors that 
possess an imrinsic. ligand sensitive protein tyrosine kinase activity (Yardcn and 
Ullrich. 1988). RTKs and their ligands arc important components in the 
determination of cell fate through signalling pathways that arc activated during 
both inn:rt<.:hratc and vertebrate den:lopment ( Pm1 son and Bernstein, 1990). The 
receptors han: an important rok in an array of cellular responses including cell 
migration. proliferation and differentiation (Fanti el al.. 1993). 
RTKs arc Type l transmembranc proteins that have their N-terrnini outside the 
cell and single rn<:mbrane-spanning regions (Van der Geer el al .. 1994). There are 
several structural features that are conserved among all kno1\n RTKs. At the N-
terminus is a signal peptide that targets the protein to the secretory pathway. This 
is followed by c1n extracellular domain of several hundred amino acids that 
contains a distinctive pattern of cystcine residues and often a characteristic array 
of structural motifs. This ligand-binding domain is the most distinguishing 
feature from other RTKs. The transmembranc domain follows. which consists of 
a stretch of hydrophobic residues that arc followed by several basic residues 
functioning as a stop-transfer signal. A juxtamernbranc region on the cytoplasmic 
side of the membrane precedes the catalytic domain. All RTKs kinases share a 
conserved catalytic domain that contains kinase residues that arc involved in 
receptor function. The C-tenninal tail is typically very hydrophilic and rich in 
small amino acids and appears to have varying functions (Y ardcn and Ullrich, 
1988). 
2 
RTKs have been classed into 14 subfamilies depending on the structure of each 
RTK as seen in Figure 1.1. Members of a given subfamily share common 
structural features that arc distinct from those found in other subfamilies (Fanti el 
al.. 1993 ). Lach subfamih· contains different combinations of recognisable 
sequence motifs in their ligand-binding domain but all catalytic domains are 
similar. 
Despitc the di\crsity of RTKs there is a great degree of commonality in the types 
of intracellular signalling patlmays initiated by these proteins. In Drosophila. 
biochemical and molecular genetic analyses ha\'e sho\111 that for all RTKs the 
binding of ligand to the extracellular domain activates the tyrosine kinase in the 
cytoplasmic domain. This leads to downstream activation of a number of 
common signalling molecules. The activation of signalling pathways involving 
these molecules kads to changes in gene expression and a change in the 
phenol) pie stale or the cell. A single type of RTK can elicit very different 
biological responses in different cell types (Fanti et al., 1993 ). l t is not clear how 
this is accomplished. 
1.2 RTKS IN DROSOPHILA 
The acti\'ation of similar signalling molecules has been confirmed through 
genetic analyses in two model systems, Caenorhabditis elegans and Drosophila 
me/anogaster. These studies have proven that RTK molecules are important for 
the developmental specification of cell types and that RTKs in these organisms 
initiate signalling pathways that are very similar to those found in mammalian 
systems (Fanti et al., 1993). 
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Figure 1. 1 Structure of the fourteen RTK subfamilies. 
Abbreviations are as follows: EGFR: epidermal grov,1h factor, IR: insulin 
receptor. PDGFR: platelet derived growth factor, F/k-2: foetal liver kinase-2, F/t-
3: fins-like tyrosine kinase-3. FGFR: fibroblast growth factor receptor, NGFR: 
nerve growth factor receptor, HCiFR: hcpatocyte growth factor receptor, DDR: 
discoid domain receptor. Adapted from Van der Geer er al (1994) by Dr Phil 
Crosier. University of Auckland. 
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In Drosophila, the signalling cascades from three RTKs have been studied 
genetically. In the emhryo. the torso (tor) RTK is present throughout the embryo 
and is required for the specification of terminal structures (Brunner et al., 1994 ). 
ln normal development an extracellular ligand activates tor at both poles of the 
embryo. There arc no terminal structures in mutants that do not express tor. Tor 
gain-of-function mutants have a receptor that is active throughout the embryo, 
leading to the generalised expression pj' the wr target gene rui/less (II!) (l'errimon 
and lksplan. 1994 ). 
Another RTK important in development in Drosophila is the EGF receptor 
homolog named DER. DER has both maternal and zygotic functions. ln the 
mother DER is required for the establishment or the dorsmentral polarity of the 
egg shell and the embryo (Schupbach. 1987). In the absence of a DER signal, a 
ventral instead of dorsal phenotype is induced ( Pawson and Bernstein. 1990). In 
the zygote. the absence of DER activity at Stages 8 and 9 of embryonic 
development results in cells adopting an altered cell fate (Raz and Shilo. 1993). 
!n contrast to DER. the sevenless (sev) gene encodes a transmembrane RTK 
whose only known biological function is the specification of a single 
photoreceptor cell of the ommatidial clusters that comprise the Drosophila 
compound eye (Zipursky and Rubin, 1994 ). In the developing eye, specification 
of the R 7 photoreceptor cell in each ommatidium depends on the local activation 
of the sev RTK in the R7 precursor cell by the membrane bound bride-of-
sevenless (boss) protein on the neighbouring RS cell (Hafen et al., 1987). 
The sevenless, torso and DER RTKs are prototypes for tyrosine kinases that 
convey positional and developmental information by interpreting cues provided 
by nearby cells (Pawson and Bernstein, 1990). This type of local cellular 
interaction is likely to have vast significance in defining the developmental fate 
of cells in Drosophila embryogenesis. 
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These three RTKs have been shown to utilise a similar signalling cascade 
(Brunner et al .. 1994) as seen in Figure 1.2. Binding of a ligand to an RTK leads to 
activation of the cytoplasmic tyrosine kinase domain. This results m 
autophosphorylation of tyrosine residues allowing the receptor to interact with 
Drk. Following this, the Drk protein binds to the son-of-sevenless (sos) guanine 
nucleotide exchange factor activating the pro1ein. Sos can now act to convert the 
inactive Ras-CillP to the active Ras-CiTP form. The Ras guanine nucleotide 
binding protein has been identified as a critical determinant of cellular 
differentiation ( A vruch et al.. 1994 ). The immediate target of Ras is Raf. a 
serine/threonine kinase that is the next member of the signal transduction cascade. 
Raf then binds and acti\ates the MAP kinas" activator MEK. \Vhich in turn 
activates MAP kinase. MAP kinase is the final compom:nt \I hose activation is hoth 
necessary and sufficient for signal transduction in the patlrnay. 
From this point. transcription factors arc phosphorylated by the pathway and 
subsequent genes are activated. In the torso path,vay the transcription factor(s) 
involved is unknown, but both 1ai/iess (r/{) and huckebein (hkb) are activated in the 
terminal n:gions in response to tor signalling <Pcrrimon and Desplan, 1994). In the 
sevenless pathway the expression of sina and yan arc not dependent on sev 
activity. but may be required to mediate regulated transcription in response to scv 
activity (Brunner et al., 1994 ). In the DER pathway neither the transcription 
factors nor genes involved in instructing dorsal follicle cell fate have yet been 
identified. 
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Figure 1. 2 Different receptors utilize a similar signalling cascade 
Components common to the tor, sev and DER pathways are shown (Brunner et 
al., 1994 ). Sec Section 1.2 for details. 
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Along with the three major RTKs. a number of other Drosophila RTKs have been 
identified. 
Dtrk is highly related to the trk farnilv oC mammalian neurotrophin receptors 
(Pulido ct al .. 1992). The product of Dirk is expressed in several areas of the 
de, eloping nervous S\ stem. The gene is thought to promote cell adhesion that 
activates its tyro.sine kinase acti\ ity. The trk fomily of receptors arc discussed 
further in Section l.3.3. 
Dror encodes a gene that is homologous to the , crtcbrate Ror family of Trk-
relatcd RTKs (Wilson ct of.. 1993). The ncurotrophic receptor functions during 
the early nervous system development in nics. This family of receptors arc 
discussed more fully in Section J .}.4 and 1.4. 
Dre/ is a homo log of the human prolO-oncogenc ret. It is transiently expressed in 
embryonic neuronal precursor cells including neuroblasts and CNS cells (Sugaya 
el al .• 1994 ). The structure of Dre/ and expression is highly related to that of 
human rel. so it is feasible that both genes arc involved in the same 
developmental process in neuronal tissues. 
The Drosophila derailed (cir!) gene is involved in key aspects of neuronal 
pathway recognition (Callahan ct al., 1995). Drl is expressed in only a small 
subset of embryonic interneurons that share common pathways. 
Lio encodes a putative RTK that is unusual as it contains a short extracellular 
domain and modified catalytic domain (Dura et al., 1995). Lio, though not vital, 
is important for learning and memory in flies. Lio mutants have weak learning 
and memory capabilities with reduced shock reactivities and olfactory associative 
memory. Both drl and Lio genes are homologous to the vertebrate gene RYK. The 
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function of RYK is unknown but evidence from Drosophila suggests the genes 
mav be inn1h ed in a new. undetermined signal transduction pathway. 
1.3 RTKs OF INTEREST 
1.3.1 DTK 
D1k is a no, d membrane bound dcvclo11111c1nal tnosinc kinase receptor that has 
been cloned recently in mice. zebra fish and humans (Crosier el al .. 1994a and b. 
Walshe cl ol.. 1995). Dtk is a well-com,cncd receptor tyrosine kinase in 
vertebrates. suggesting an important biological function. It is expressed in rnany 
tissues during crnbn ogcncsis and i, strontd) cxprc;,scd in the adult brain and 
other tissues to a lesser extent. The 850 amino acid mature receptor protein 
comprises an extracellular domain with two immunoglobulin-likc motifs and two 
fibronectin type Ill modules. a 25 amino acid transmcmbranc domain and a 
cytoplasmic region with a catalytic kinase domain (Crosier et al., 1994a). 
There are two repeating protein motib ,1·ithin the domain. Orn: of these contains 
two C-type immunoglobulin like motifs. the first domain has similar structure to a 
C ]-like domain. while the second is more related to the C2-like domain. Also in 
the domain are two fibronectin type Ill motifs. Like Dtk, Ax] (Ufo, Ark) also 
contains two immmunoglobulin domains followed by two fibronectin type III 
repeats in the extracellular domain (Crosier et al., 1994a). 
The mouse Dtk gene was first isolated from embryonic stem (ES) cells (Crosier et 
al., 1994a). Using RNA isolated from differentiating ES cells, a number of RTKs 
were isolated that were potentially involved in haematopoietic development. 
Degenerate oligonucleotides derived from conserved domains within the catalytic 
kinase domain of protein tyrosine kinases were constructed and used in PCR 
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reactions to isolate the RTKs. /\ number of sequences from putative and known 
RTKs \\CIT found. one ohvhich was designated Dtk 
In embryonic stem cells and embryonic bodies. Dtk is expressed almost uniformly 
from days 0-18. Within the embryonic tissues expression was detected in total 
RN/\ from a range of tissues including the brain. eye. thymus. lung. intestine, 
forelimb. hindlimb. and testis. There was limited cxpressiun in the heart and 
unfractionated Ii\ er. In the adult tissues the pattern of expression becomes 
restricted. Transcripts 1wrc greatest in the brain. oesophagus. bladder, testis and 
oYary. In the brain the expression of Dd 11 as mmc abundant in the adult than in 
embn onic tissue. Tht:rc were also traces of Dtk in the lung. stomach and in the 
intestines (Crosier et al .. 1994a). 
The human Dtk gene was isolated using the rnurine Dtk cDNA as a probe to 
screen a human brain cDNA library by Crosier et al. (1994b). This gene is 
identical to the human Tvro3 gene cloned by Pol vi et al. (] 993 ). The protein has 
identical predicted structural features to those of the murine Dtk. and there is an 
89 % amino acid identity between the two genes. 
To analyse the expression of Dtk in humans, Northern biol hybridisation was 
carried out. Dtk was shown to be expressed in foetal brain and kidney, as well as 
low levels in foetal lung and heart (Crosier et al., 1994b). In adult tissues Dtk 
expression was found in the brain, kidney, testis and ovary. Limited expression 
was seen in the other adult tissues with no expression in the peripheral blood 
leucocytes and liver. Thus, the pattern of expression was very similar to murine 
Dtk, with the notable exception that there is little expression in the adult kidney 
(Crosier et al., 1994b ). 
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1.3.2 EPH 
The Fph subfamil: is the largest of the RTKs "ith l3 receptors and 7 of their 
ligands identified in mammals to date (Muller cl a/ .. 1996). The Eph subfamily of 
receptors comprise an extracellular domain that includes one immunoglobulin-
likc motiL two fibroncctin type Ir! repeats and a cysteinc rich region. a 
lwdroph1)hic region comprising the transmcmbranc domain and a cytoplasmic 
region ,,ith a catalytic kinase domain (Van dcr C1ccr el al.. 1994). 
The first receptor isolated in the Eph subfamily ,,as identified by Hirai el al. 
( 1987) in a human genomic DNA libran during a search for sequences 
honrnlogous !() the tvrosine kinase domain of 1·:/p.1 ( a ,·iral oncogene). Following 
this. the remainder members of the farnil:, were idrntifo.:cl frum various vcr1ebratc 
species including humans, mouse. rat. Xenop11s and zcbrafish (Pandey el al .. 
l 995). 
Most of these receptors are specifically expressed in neurons, but the biological 
functions of many of the Eph-typc RTKs are unknown. Ligand binding to an Eph 
RTK appears to lead to activation of a novel signal transduction pathway. For 
example. activation of the cctopicatly expressed receptors does not lead (as 
expected) to a biological response from the cell (Muller et al., 1996 ). 
Another unique feature of this subfamily is that only the membrane-bound forms 
of ligands are active, leading to speculation that these receptors play roles in axon 
guidance, neuronal bundling or angiogenesis (Stein et al., 1996). More 
specifically it has been suggested that these receptors and ligands may play a 
significant role in forming topographic projections along the anteroposterior axis 
of the tecturn (Tessier-Lavigne, I 995). The tectum is the structure in the brain 
that transmits the retinal image to the brain by rectifying the back-to-front, 
upside-down image. To do this, the anterior and posterior ganglion cells map to 
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the posterior and anterior tectum. and the dorsal and ventral ganglion cells map to 
the ventral and dorsal tcctum ( Orike and Pini. 1996 ). Studies performed on the 
chicken shov,cd the presence of a retinotectal projection in which retinal ganglion 
cell axons project in a topographic manner onto the optic tectum, the target area. 
It is thought that complementary gradients of receptors in the retina and of 
corresponding ligands in the optic tectum arc crucial for the formation of this 
projection (Muller cl al .. l 996). 
As well as this. expresswn of some Eph-relatcd molecules in migratory cells 
suggests a further rok of these receptors in the prc1ccss of cell migration (Muller 
el al.. l 996 ). Thus i1 appears that Eph-lypc RTKs play important roles in 
maintaining and dc\cloping many cell and tissue t\pcs. 
1.3.3 TRK 
The Trk receptors belong to the Nerve Growth Factor (NGF) receptor subfamily 
of RTKs. The NGF receptors comprise an extracellular domain that includes a 
leucine rich region and two irnmunoglobulin-like motifs, a transmembrane 
domain and a cytoplasmic region with a catalytic kinase domain (Yan der Geer et 
al, 1994). 
The original member of this family, proto-trk ( Martin-Zanca et al., I 986 ). was 
named after the human oncogenic product TRK, a cytosolic non-muscle 
tropomyosin receptor kinase fusion protein. This was renamed TrkA when two 
other members of this group were identified. TrkB (Klein et al., 1990) and TrkC 
(Lamballe et al., 1991 ). The Trk receptors share structure and sequence 
similarities and have been shown to bind similar ligands. 
All three Trk genes are almost exclusively expressed in neurons and are the 
receptors for neurotrophins. Each neurotrophin activates specific receptors by 
binding to their extracellular domains. TrkA is a receptor for NGF the best 
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characterised neurotrophin, TrkB for BDNF and NT-4/5 and TrkC for NT-3 
(Grimes et al., 1993). These neurotrophins induce neurite outgrowth and rescue 
subpopulations of neurons from programmed cell death (Glass and Yancopoulos, 
1993). In addition to the Trks, neurotrophins all bind to another cell surface 
receptor knovm as p75 or the low-affinity NGF receptor, whose physical role 
remains to be determined (Barbacid, 1993 ). 
1.3.4 ROR 
Ror 1 and Ror2 are t\vo novel developmentally regulated receptor tyrosine kinases 
cloned from humans and rats (Masiakmvski and Carroll. 1992). Both genes are 
highly expressed in the rat in the brain and body in early embryogcnesis, 
suggesting a role in the development of the embryo. The Ror RTKs are thought to 
be involved in a nct\vork of regulatory interactions, including a possible role in 
signal transduction pathways and in cell-cell interactions. Rorl and Ror2 contain 
one strongly homologous region to the Trk family of nerve growth factor 
receptors, the tyrosine kinase domain, but because of a unique extracellular 
region it appears they represent a new subfamily of R TKs (Van der Geer et al., 
1994). 
The 937 (Rorl) and 943 (Ror2) amino acid mature receptor proteins comprise an 
extracellular domain with one immunoglobulin-Iike motif: a cysteine rich region 
and a kringle domain, a hydrophobic region comprising the transmembrane 
domain and a cytoplasmic region with a catalytic kinase domain (Masiakowski 
and Carroll, 1992). The Rorl and Ror2 proteins are highly homologous, 
displaying an overall amino acid identity of 58 %. 
A kringle domain is a cysteine-rich structure thought to participate in protein-
protein interactions (Patthy et al., 1984). Kringle domains have been identified in 
multiple copies in certain proteins involved in blood clotting, (Kanalas and 
Makker, 1991; Patthy, 1985), apolipoprotein( a) (McLean et al., 1987) and 
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hepatocyte growth factor (Nakamura et al., 1989; Seki et al., 1991). Kringle 
domains have also been found in one muscle-specific RTK. The electric ray 
Torpedo californica possesses a kringle domain in the extracellular domain of the 
muscle-specific RTK (Jennings et al., 1993). This RTK is thought to be part of 
the family of mammalian MuSKs (muscle-specific kinases ), but is the only one to 
contain this kringle domain (Valenzuela et aL 1995). 
The cytoplasmic catalytic domains of Rorl and Ror2 are very similar to the Trk 
kinase domain. For example. the kinase domains of Rorl and Trk are 47 % 
identical (Masiakowski and CarrolL l 992). 
Cloning of Ror l and Ror2 in humans and rats was undertaken using PCR with 
degenerate oligonucleotide primers designed to conserved regions of Trk specific 
clusters of amino acids. Trk and TrkB sequences were eliminated by treating the 
PCR products with restriction enzymes expected to cut these genes. The 
remaining fragments \Vere reamplified and cloned. These bacterial colonies were 
screened by PCR followed by direct sequencing, a cDNA library was screened 
with these fragments and the longest cDNA inserts sequenced. 
To verify the enzymatic activity of Ror1 and Ror2, in vitro autophosphorylation 
of the immunoprecipitated kinase was undertaken. Data indicated that the protein 
kinase activity is specifically associated with the tyrosine kinase domain of Ror2, 
but results from Ror l were inconclusive. 
To analyse the expression of Ror 1 and Ror 2 in rats, Northern blot analysis was 
performed. Both Ror 1 and Ror 2 are highly expressed in the head and body during 
early embryonic development with the peak of expression at embryonic day 12. 
The level of expression drops drastically at embryonic day 16 and expression 
remains very low in adult rats. In contrast expression of trkB increases in the later 
stages of embryonic development (Klein et al., 1990). 
16 
1.4 CLONING ROR IN DROSOPHILA 
The Drosophila homologue of Ror (Dror) was cloned by Wilson et al. (1993) by 
screening a late third instar larval brain cDNA library using a PCR-based 
approach. Degenerate oligonucleotide primers designed to two conserved regions 
in the tyrosine kinase domain. Resulting clones were subcloned and sequenced, 
one of which was designated Dror. 
Dror encodes a 685 ammo acid mature receptor protein comprising an 
extracellular domain containing a cystcine rich region and a kringle domain, a 
hydrophobic transmembrane domain and a cytoplasmic region \Vith a catalytic 
kinase domain (Wilson et al .. 1993 ). The Dror receptor demonstrates a 44 % 
identity with human Ror 1, 40 %i identity to human Ror2 and 3 2 % identity to 
human TrkB. Extensive sequence similarity between the Ror proteins and Dror is 
seen throughout the length. However, Dror lacks the irnmunoglobulin-like 
domain found in the extracellular domain of Rorl and Ror2. Dror also lacks the 
extensive carboxyl terminus tail found in Rorl and Ror2. 
The tyrosine kinase domain of Dror shows significant similarity to the Rorl, Ror2 
and Trk proteins of between 53 % and 61 %. A number of the shared amino acids 
in this domain are not found in many other R TKs suggesting the occurrence of a 
Trk-like superfamily of RTKs. Although Dror demonstrates the highest identity 
to Ror 1 in the tyrosine kinase region ( 61 % ), Dror does not share some of the 
features that distinguished the Ror genes from the Trk genes in this region. 
Within the extracellular domain, Dror shares a 36 % identity with Ror 1 and 34 % 
with Ror2, but no significant similarities to the Trk family. Like Rorl and Ror2, 
Dror contains a cysteine-rich region and a kringle domain, but within the 
cysteine-rich region is a unique 55 amino acid lysine-rich insert. When these 
three proteins are aligned all 16 cysteines in this region in Ror I and Ror2 have 
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equivalent positions in the Dror protein. The immunoglobulin-like domain seen in 
Rorl and Ror2 is not present in Dror. hence the cystcine rich region is positioned 
close to the amino terminus of Dror. 
111 situ hybridisation of whole mount embryos was performed to examme the 
expression of Dror. There \Vas no expression of Dror in early embryos (Stage J-
I 0, 1-8 hours), but ,,as seen at Stages l l ( extended germ-band stage) to Stage 15 
( 8- l 2 hours). Most of the neurons within the brain and wntral cord expressed 
Dror, as well as some cells in the head and trunk representing organs of the 
peripheral nervous system. No expression of Dror was seen outside the nervous 
system suggesting an important role of the Ror proteins in early nrnral 
differentiation and less important innihemcnt in neuronal cell survival. 
1.5 AIMS OF THIS THESIS 
The original aim of the project was to clone the Drosophila me/anogaster 
homologue of the human Dtk gene. This was to be accomplished by using the 
polymerase chain reaction (PCR) with degenerate oligonucleotides derived from 
conserved amino acid motifs within the tyrosine kinase domain. 
Clones from four novel putative RTKs were isolated, but none were similar to 
Dtk. Thus, we were required to change the original aim of this thesis. The new 
aim was to characterise the gene for one of the novel RTKs, we subsequently 
called Dror2. The specific objectives were to first detennine the sequence and 
structure of the Dror2 gene. The latter included mapping intron-exon boundaries, 
transcription start point and poly A+ site. The second objective was to determine 
the temporal and spatial pattern of expression of the Dror2 gene. The former 
would be accomplished by using both RT-PCR and Northern blots on RNA 
isolated from various stages of Drosophila development. The pattern of 
expression would be determined by in situ hybridisation. 
